Clinical Trials on Edematous Fibrosclerotic Panniculopathy in Sweden

Total 22 results

Allerderm

Completed

Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study

Contact Dermatitis

Sweden
Region Skane

Completed

Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy (ISICA-13)

Dermatitis, Allergic Contact

Sweden
DermaGen AB

Completed

A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060

Atopic Dermatitis

Sweden
ACO Hud Nordic AB

Unknown

Effect of Moisturizing Creams on Skin Barrier Function

Atopic Eczema

Sweden
Karolinska Institutet

Completed

Internet-based Mindfulness and Exposure Treatment for Atopic Dermatitis

Atopic Dermatitis

Sweden
Karolinska Institutet

Completed

Cognitive Behavior Therapy for Atopic Dermatitis

Atopic Dermatitis

Sweden
Ostergotland County Council, Sweden

Unknown

Treatment of IgE Associated Eczema With Omega-3 Long Chain Polyunsaturated Fatty Acids in Infancy and the Development of Bronchial Asthma in Childhood (Omega-Treat)

Eczema | Food Allergy | Sensitisation

Sweden
Karolinska Institutet
Karolinska University Hospital

Active, not recruiting

Therapist-guided vs Self-guided CBT for AD: Non-inferiority Trial

Atopic Dermatitis

Sweden
Umeå University
Karolinska Institutet; Medical Research Council; University of Helsinki; Ekhaga... and other collaborators

Completed

Probiotics in Prevention of Allergies, Obesity and Caries (ELEFANT)

Obesity | Asthma | Allergy | Dental Caries | Eczema

Sweden
ACO Hud Nordic AB

Completed

Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser

Atopic Eczema

Sweden
Herlev and Gentofte Hospital
Göteborg University; University of Copenhagen; Sahlgrenska University Hospital...

Completed

Low Dose Exposure to Oxidized R-limonene - A Repeated Open Application Test (ROAT) Study

Allergic Contact Dermatitis Due to Cosmetics

Denmark, Sweden
Moberg Pharma AB

Completed

Two Topical K40 Formulations in Adults With Seborrhoeic Dermatitis (SD) of the Scalp

Seborrhoeic Dermatitis of the Scalp

Sweden
Moberg Pharma AB

Completed

K301 for the Treatment of Seborrhoeic Eczema (SE) of the Scalp

Seborrhoeic Eczema of the Scalp

Sweden
Galderma R&D

Completed

An Efficacy and Safety Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis

Prurigo Nodularis

United States, Germany, Austria, Canada, Denmark, Hungary, Italy, Poland, Sweden, United Kingdom
Galderma R&D

Active, not recruiting

A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Prurigo Nodularis

United States, Belgium, Canada, France, Korea, Republic of, Netherlands, Poland, Spain, Switzerland, Austria, Denmark, Germany, Hungary, Italy, Sweden, United Kingdom
Pfizer

Terminated

A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD

Atopic Dermatitis

United States, Poland, Germany, United Kingdom, Italy, Sweden, Switzerland
Regeneron Pharmaceuticals
Sanofi

Completed

Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis (SOLO 2)

Dermatitis, Atopic

United States, France, Poland, United Kingdom, Germany, Hong Kong, Canada, Korea, Republic of, Italy, Lithuania, Sweden
Sanofi

Recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)

Dermatitis Atopic

Argentina, Japan, China, Czechia, Spain, United States, South Africa, United Kingdom, Denmark, Sweden, Turkey
AbbVie

Completed

A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis (Heads Up)

Atopic Dermatitis

United States, Australia, Canada, Croatia, Czechia, Finland, France, Germany, Hungary, Ireland, Israel, Italy, Malaysia, Netherlands, New Zealand, Norway, Poland, Singapore, Spain, Sweden, Taiwan, Ukraine, United Kingdom
Amgen

Active, not recruiting

A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) (ROCKET-Horizon)

Atopic Dermatitis

United States, Spain, United Kingdom, Korea, Republic of, Australia, Denmark, Germany, Belgium, Canada, Japan, Sweden, Poland, Romania, Estonia, Brazil, Czechia, Portugal, Finland, Mexico, Turkey, South Africa
AbbVie

Enrolling by invitation

A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis (AD Up)

Atopic Dermatitis

United States, Australia, Austria, Belgium, Canada, China, Czechia, France, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Netherlands, New Zealand, Norway, Puerto Rico, Slovakia, Spain, Sweden, United Kingdom
AbbVie

Active, not recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis (Level Up)

Atopic Dermatitis

United States, Australia, Belgium, Bulgaria, Canada, China, Denmark, France, Germany, Hungary, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Portugal, Puerto Rico, Romania, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwa... and more

3

Subscribe